Metastasis-associated lung adenocarcinoma transcript 1
MALAT1rnaMALAT1 regulates inflammatory immune-cell recruitment and atherosclerotic plaque development.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleLong-chain ncRNA regulating immune-cell differentiation and vascular inflammation in atherosclerosis.
Also acts inEndothelial activation/erosion
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000251562
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I30
C — confounder / Type-II76
A — assay feasibility50
E — evidence strength28
T1DI (composite)4
Specificity differential (R−C)-45.6
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood (transcript)
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(2)
- A novel circulating biomarker lnc-MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events.Journal of clinical laboratory analysis · 2022 · PMID 36378551 · doi
- Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-/-mice.Cardiovascular research · 2019 · PMID 30101304 · doi